However, knowing the G6PD status of a patient is useful clinical information and the cost of implementing POC for G6PD deficiency testing service at rural PHC clinics by the Government of Ghana should not be a reason to deny a special sub-population such as pregnant women and newborns access to G6PD deficiency testing because Ghana is a malaria-endemic country. The gene discussed is G6PD; the disease is G6PD deficiency.